Victory Capital Management Inc Fusion Pharmaceuticals Inc. Transaction History

Victory Capital Management Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$2.0 - $3.56 $262,020 - $466,395	-131,010 Reduced 72.22%	50,390 $152,000
Q2 2022 Aug 01, 2022	SELL	$2.49 - $7.86 $5,702 - $17,999	-2,290 Reduced 1.25%	181,400 $451,000
Q1 2022 May 04, 2022	SELL	$4.53 - $8.57 $302,105 - $571,533	-66,690 Reduced 26.64%	183,690 $1.3 Million
Q4 2021 Feb 07, 2022	SELL	$4.17 - $7.78 $72,236 - $134,772	-17,323 Reduced 6.47%	250,380 $1.04 Million
Q3 2021 Nov 02, 2021	SELL	$7.83 - $9.41 $15,033 - $18,067	-1,920 Reduced 0.71%	267,703 $2.12 Million
Q2 2021 Aug 03, 2021	SELL	$7.97 - $10.66 $127,958 - $171,146	-16,055 Reduced 5.62%	269,623 $2.18 Million
Q1 2021 May 04, 2021	BUY	$9.75 - $13.09 $1.04 Million - $1.39 Million	106,154 Added 59.13%	285,678 $3.06 Million
Q4 2020 Feb 01, 2021	BUY	$11.5 - $13.73 $321,034 - $383,286	27,916 Added 18.41%	179,524 $2.11 Million
Q3 2020 Nov 09, 2020	SELL	$11.8 - $17.1 $378,980 - $549,200	-32,117 Reduced 17.48%	151,608 $1.82 Million
Q2 2020 Aug 07, 2020	BUY	$17.0 - $17.78 $3.12 Million - $3.27 Million	183,725 New	183,725 $3.21 Million

93K

1.4K

Ticker FUSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,390,500
Description
Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.